The psoriatic arthritis treatment market value was USD 13.38 Billion in 2024, driven by the prevalence of psoriatic arthritis across the globe. The market size is anticipated to grow at a CAGR of 9.80% during the forecast period of 2025-2034 to achieve a value of USD 34.08 Billion by 2034.
It is estimated that psoriasis affects more than 125 million individuals around the globe, and psoriasis tends to create psoriatic arthritis in 30% of the population. The global industry for psoriatic arthritis treatment is influenced by an increasing acceptance of medical therapy by patients suffering from moderate to serious psoriatic arthritis.
This product will be delivered within 3-5 business days.
It is estimated that psoriasis affects more than 125 million individuals around the globe, and psoriasis tends to create psoriatic arthritis in 30% of the population. The global industry for psoriatic arthritis treatment is influenced by an increasing acceptance of medical therapy by patients suffering from moderate to serious psoriatic arthritis.
Market Segmentation
Psoriatic arthritis is a chronic psoriasis-related degenerative disorder. Swollen fingers, toes, and tender joints, stiffness, lowered back pain, and pitted nails are prevalent symptoms of psoriatic arthritis. Psoriatic arthritis treatment market can be divided on the basis of segments like drug class, product type and administration route.Market Breakup by Drug Class
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Disease-Modifying Antirheumatic Drugs (DMARDs)
- Immunosuppressants
- Biological Agents
- Corticosteroids
- Others
Market Breakup by Route of Administration
- Oral
- Parenteral
- Topical
Market Breakup by Drug Type
- Prescription
- Over The Counter
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Analysis
The intensive research taking place to provide treatment to the patients suffering from psoriasis condition is driving the global psoriatic arthritis treatment industry. The other factors aiding in the growth of the industry are investments by major companies in clinical R&D, new product launches, increasing disease prevalence and proactive government initiatives. The factors such as high cost of treatment, stringent regulatory approval and adverse effect of drugs may hinder the growth of the market in coming future.Competitive Landscape
The report presents a detailed analysis of the following key players in the global psoriatic arthritis treatment industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:- AbbVie Inc.
- Janssen Global Services, LLC (Johnson & Johnson)
- Novartis AG
- Amgen Inc.
- Biogen Inc.
- Pfizer Inc.
- Eli Lilly and Company
- UCB S.A.
- Bristol-Myers Squibb Company
- Merck & Co. Inc.
- Others
Key Highlights of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:- Drug Class
- Route of Administration
- Drug Type
- Distribution Channel
- Region
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Disease-Modifying Antirheumatic Drugs (DMARDs)
- Immunosuppressants
- Biological Agents
- Corticosteroids
- Others
- Oral
- Parenteral
- Topical
- Prescription
- Over The Counter
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Market Drivers and Constraints
- SWOT Analysis
- Porter's Five Forces Model
- Key Demand Indicators
- Key Price Indicators
- Industry Events, Initiatives, and Trends
- Value Chain Analysis
- Market Structure
- Company Profiles
- Financial Analysis
- Product Portfolio
- Demographic Reach and Achievements
- Mergers and Acquisitions
- Certifications
- AbbVie Inc.
- Janssen Global Services, LLC (Johnson & Johnson)
- Novartis AG
- Amgen Inc.
- Biogen Inc.
- Pfizer Inc.
- Eli Lilly and Company
- UCB S.A.
- Bristol-Myers Squibb Company
- Merck & Co. Inc.
- Others
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Psoriatic Arthritis Overview
4 Patient Profile
5 Psoriatic Arthritis Epidemiology Analysis
6 Global Psoriatic Arthritis Treatment Market Overview
7 Global Psoriatic Arthritis Treatment Market Landscape
8 Psoriatic Arthritis Therapeutics Challenges and Unmet Needs
10 Global Psoriatic Arthritis Treatment Market Dynamics
11 Global Psoriatic Arthritis Treatment Market Segmentation
12 North America Psoriatic Arthritis Therapeutics Market
13 Europe Psoriatic Arthritis Therapeutics Market
14 Asia Pacific Psoriatic Arthritis Therapeutics Market
15 Latin America Psoriatic Arthritis Therapeutics Market
16 Middle East and Africa Psoriatic Arthritis Therapeutics Market
17 Regulatory Framework
18 Patent Analysis
19 Grants Analysis
20 Clinical Trials Analysis
21 Funding and Investment Analysis
22 Partnership and Collaborations Analysis
23 Supplier Landscape
24 Psoriatic Arthritis Therapeutics - Distribution Model (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
27 Payment Methods (Additional Insight)
Companies Mentioned
- AbbVie Inc.
- Janssen Global Services, LLC (Johnson & Johnson)
- Novartis AG
- Amgen Inc.
- Biogen Inc.
- Pfizer Inc.
- Eli Lilly and Company
- UCB S.A.
- Bristol-Myers Squibb Company
- Merck & Co. Inc.
- Others
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 350 |
| Published | July 2025 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value ( USD | $ 13.38 Billion |
| Forecasted Market Value ( USD | $ 34.08 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
